ArticleRevista de salud publica (Bogota, Colombia)2023
[Characterization of infectious conjunctivitis in a fourth-level care center, Bogota, Colombia].
Article in Revista de salud publica (Bogota, Colombia), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: The purpose of this study is to describe the characteristics of the populations that consulted to the emergency service due to conjunctivitis from March 1 of 2019 to March 1 of 2021 and evaluate the frequency of presentation of contagious ocular pathologies like is the case of bacterial conjunctivitis. Methods: A descriptive cross-sectional study was conducted in a historical cohort in the Department of Surgery, Ophthalmology Unit of the Hospital Universitario San Ignacio, Bogotá D.C. from March 2019 to March 1, 2021. The study included patients with a diagnosis of bacterial conjunctivitis and patients with a diagnosis of superinfected viral conjunctivitis, and excluded all patients with a positive result for COVID-19 and patients with symptoms suggestive of SARS-infectionCoV-2. Of the patients, 629 met the selection criteria. Results: Between March 2019 and April 2020, 534 consultations were registered in the emergency department of the ophthalmology unit, and from April 24, 2020 (when resolution 666 on biosecurity measures started) until March 2021, 95 consultations were registered. The majority of the patients presented with viral conjunctivitis, followed by superinfected viral conjunctivitis, and bacterial conjunctivitis. Conclusion: We hypothesize that biosecurity measures such as isolation, frequent hand washing, and the use of face masks could explain the marked reduction in cases of infectious conjunctivitis in the community.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.